| Ident. | Authors (with country if any) | Title |
|---|
| 000019 (2020) |
Gary J. Haderski ; Bojidar M. Kandar ; Craig M. Brackett ; Ilia M. Toshkov [États-Unis] ; Christopher P. Johnson ; Geraldine M. Paszkiewicz ; Venkatesh Natarajan ; Anatoli S. Gleiberman [États-Unis] ; Andrei V. Gudkov ; Lyudmila G. Burdelya | TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects. |
| 000112 (2020) |
Ryan A. Lafferty [Royaume-Uni] ; Neil Tanday [Royaume-Uni] ; Peter R. Flatt [Royaume-Uni] ; Nigel Irwin [Royaume-Uni] | Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction. |
| 000199 (2019) |
Jolanta Wiejak [Royaume-Uni] ; Boy Van Basten [Royaume-Uni] ; Urszula Luchowska-Sta Ska [Royaume-Uni] ; Graham Hamilton [Royaume-Uni] ; Stephen J. Yarwood [Royaume-Uni] | The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs). |
| 000611 (2019) |
Fei Wang [République populaire de Chine] ; Yanchang Shang [République populaire de Chine] ; Rong Zhang [République populaire de Chine] ; Xiangyang Gao [République populaire de Chine] ; Qiang Zeng [République populaire de Chine] | A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms. |
| 000675 (2018) |
David Brown [Royaume-Uni] ; Kevin Ryan [Royaume-Uni] ; Zoe Daniel [Royaume-Uni] ; Molebeledi Mareko [Royaume-Uni, Botswana] ; Richard Talbot [Royaume-Uni] ; Joanna Moreton [Royaume-Uni] ; Tom C B. Giles [Royaume-Uni] ; Richard Emes [Royaume-Uni] ; Charlie Hodgman [Royaume-Uni] ; Tim Parr [Royaume-Uni] ; John M. Brameld [Royaume-Uni] | The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program. |
| 000760 (2018) |
Wen-Da Wang [République populaire de Chine] ; Rui Sun [République populaire de Chine] ; Yue-Xin Chen [République populaire de Chine] | PPARγ agonist rosiglitazone alters the temporal and spatial distribution of inflammation during abdominal aortic aneurysm formation. |
| 000949 (2018) |
Panhu Zhu [République populaire de Chine] ; Weijun Huang [République populaire de Chine] ; Jiaming Li [République populaire de Chine] ; Xiaodong Ma [République populaire de Chine] ; Mengqi Hu [République populaire de Chine] ; Yujun Wang [République populaire de Chine] ; Qinlong Xu [République populaire de Chine] ; Xianna Wang [République populaire de Chine] | Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes. |
| 000953 (2018) |
R V Knox [États-Unis] ; K R Stewart [États-Unis] ; W L Flowers [États-Unis] ; M E Swanson [États-Unis] ; S K Webel [États-Unis] ; R R Kraeling [États-Unis] | Design and biological effects of a vaginally administered gel containing the GnRH agonist, triptorelin, for synchronizing ovulation in swine. |
| 000C76 (2017) |
Shinji Iwasaki [Oman] ; Teruki Hamada [Japon] ; Ikumi Chisaki [Japon] ; Tomohiro Andou [Japon] ; Noriyasu Sano [Japon] ; Atsutoshi Furuta [Japon] ; Nobuyuki Amano [Japon] | Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice. |
| 001503 (2015) |
Thomas L. Mccarthy [États-Unis] ; Michael Centrella | Prostaglandin dependent control of an endogenous estrogen receptor agonist by osteoblasts. |
| 001A68 (2014) |
Yasuhiko Kubota [Japon] ; Shigeru Miyagawa [Japon] ; Satsuki Fukushima [Japon] ; Atsuhiro Saito [Japon] ; Hiroshi Watabe [Japon] ; Takashi Daimon [Japon] ; Yoshiki Sakai [Japon] ; Toshiaki Akita [Japon] ; Yoshiki Sawa [Japon] | Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model. |
| 001F85 (2012) |
J C Morales-Medina [Canada] ; S. Dominguez-Lopez ; G. Gobbi ; A G Beck-Sickinger ; R. Quirion | The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. |
| 002066 (2012) |
Mi Young Lee [Corée du Sud] ; Ran Choi ; Hong Min Kim ; Eun Ju Cho ; Bo Hwan Kim ; Yeon Sik Choi ; Jarinyaporn Naowaboot ; Eun Young Lee ; Young Chul Yang ; Jang Yel Shin ; Young Goo Shin ; Choon Hee Chung | Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism. |
| 002609 (2011) |
Ryouta Kogure [Japon] ; Kazuya Toyama ; Shuichi Hiyamuta ; Itaru Kojima ; Shigeki Takeda | 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion. |
| 002992 (2009) |
Shilpa Oak [États-Unis] ; Cang Tran ; Maria-Olivia Castillo ; Shanthie Thamotharan ; Manikkavasagar Thamotharan ; Sherin U. Devaskar | Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring. |
| 002B60 (2009) |
Cheng-Hao Jin [Corée du Sud] ; Su Young Chae ; Sohee Son ; Tae Hyung Kim ; Key An Um ; Yu Seok Youn ; Seulki Lee ; Kang Choon Lee | A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice. |
| 002E00 (2008) |
Shmuel Hess [Israël] ; Yaniv Linde ; Oded Ovadia ; Eli Safrai ; Deborah E. Shalev ; Avi Swed ; Efrat Halbfinger ; Tair Lapidot ; Ilan Winkler ; Yael Gabinet ; Avi Faier ; Dana Yarden ; Zhimin Xiang ; Federico P. Portillo ; Carrie Haskell-Luevano ; Chaim Gilon ; Amnon Hoffman | Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. |
| 002E18 (2008) |
Lyudmila G. Burdelya [États-Unis] ; Vadim I. Krivokrysenko ; Thomas C. Tallant ; Evguenia Strom ; Anatoly S. Gleiberman ; Damodar Gupta ; Oleg V. Kurnasov ; Farrel L. Fort ; Andrei L. Osterman ; Joseph A. Didonato ; Elena Feinstein ; Andrei V. Gudkov | An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. |
| 002E79 (2007) |
Anderson J. Ferreira [Brésil] ; Bruno A. Jacoby ; Cícero A A. Araújo ; Filipe A F F. Macedo ; Gerluza A B. Silva ; Alvair P. Almeida ; Marcelo V. Caliari ; Robson A S. Santos | The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. |
| 003233 (2006) |
P W Concannon [États-Unis] ; M. Temple ; A. Montanez ; L. Newton | Effects of dose and duration of continuous GnRH-agonist treatment on induction of estrus in beagle dogs: competing and concurrent up-regulation and down-regulation of LH release. |
| 003495 (2005) |
A C Berends [Pays-Bas] ; P G M. Luiten ; C. Nyakas | A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke. |
